Tag: diagnostics market

Major Changes at Dade Behring Soon to Be Visible In Lab Market

Its recent financial restructuring now complete, Dade Behring prepares a “brand building” campaign

CEO SUMMARY: Dade Behring is poised to become a tough and high-profile competitor in the laboratory diagnostics marketplace. Earlier this month, it finalized a major financial restructuring. Following two years of negotiations with its banks and bondholders, Dade filed a “pre-pack- aged” Chapter

View Article

Sigma-Aldrich, Ivax Diagnostics, i-STAT, Quest Diagnostics, Unilab

SIGMA-ALDRICH SELLS ITS EIA PRODUCT LINE TO IVAX DIAGNOSTICS
FOLLOWING ITS DECISION TO EXIT the clinical diagnostics market, Sigma-Aldrich, Inc. has sold its global enzyme immunoassay (EIA) product line to Ivax Diagnostics, Inc., based in Miami, Florida.

The sale occurred on May 15. Sigma-Aldrich, through its Sigma Diagnostics division, was selling EIA instruments and reagents produced by

View Article

DIANON Systems, United Health, Aetna, Quest Diagnostics, Orchid, AmeriPath

DIANON SYSTEMS INKS NATIONAL AGREEMENT WITH UNITEDHEALTHCARE
A NEW NATIONAL AGREEMENT between DIANON Systems, Inc. and UnitedHealthcare was announced last week.

The agreement allows DIANON Systems to provide pathology and genetic testing services to all the beneficiaries in health plans offered by UnitedHealthCare, a division of UnitedHealth Group. It consolidates a number of existing agreements between the

View Article

Beckman Coulter Positions Itself For Biotech Testing Continuum

CEO SUMMARY: Here’s a little-known side to diagnostics giant Beckman Coulter Inc. Its efforts to expand into the fields of biomedical R&D and clinical research is a strategic shift designed to give it early access to promising technology that could be introduced into the clinical diagnostics marketplace. In this exclusive interview, John (Jack) Wareham, Chair,

View Article

Quantum Dot Corporation, Healtheon/WebMD, Illumea

QUANTUM DOT CORP. TO COLLABORATE WITH GENENTECH
PROGRESS IS SWIFT AT Quantum Dot Corporation, based in Palo Alto, California. Quantum Dot announced an agreement to collaborate with Genentech, Inc., headquartered in San Francisco, California. The goal is to evalute Qdot™ nanocrystals in a number of Genentech’s biological research assays.

Quantum Dot also raised another $30 million in

View Article